What’s teased as “The #1 Stock to Profit from the Big Biotech Boom?”

Checking out the teaser pitch from Biotech Millionaire

By Travis Johnson, Stock Gumshoe, July 15, 2020

Today we’re headed into the wild and woolly world of biotech once again, sniffing out the secret stock from a teaser pitch for Biotech Millionaire, edited by Chris Wood and Jake Weber over at Mauldin Economics ($1,795/yr, includes their Healthy Returns letter… and unlike most higher-cost letters these days, they actually offer a 30-day refund period, so we should say “good for them” on that front).

The ad begins with a spiel about the “Hawking Factor” — which, to summarize, is basically the idea that a treatment that can offer reversal of a disease… some sort of regenerative factor… is far more valuable than a drug that can just stop its progression. There are drugs for ALS, for example, but none that reverse it, and therefore Stephen Hawking was treated for his slow deterioration and was able to live for 50 years with ALS, but a revolutionary treatment would have been one that actually reversed the disease. Here’s how they put it:

“A treatment that doesn’t just save the life of the patient…

“…but could completely transform it by reversing the symptoms.

“Reversing disease is the latest example of revolutionizing science, which Hawking was all about.”

So that’s the idea, which probably means we’re dealing with something in regenerative medicine, either stem cells or something similar. What, then, is this secret biotech that they dangle before us as we fumble for our credit cards? Apparently they’re also a bit topical, and they’re doing something that might help COVID-19 patients… this is how they sum it up on the order form:

“This company is testing a groundbreaking treatment for stroke and ARDS, the leading cause of death in COVID-19 patients… for projected gains of up to 1,270% in the next 12–18 months.”

The primary focus of the company seems to be on treatment for strokes, here’s a bit about that from the ad:

“… it aids doctors in the fight against one of the world’s largest killers: stroke.

“According to the CDC, acute ischemic strokes strike almost 800,000 Americans per year and kill 140,000.

“There are about 15 million cases of stroke worldwide every year.

“Stroke is the #1 cause of disability and the #3 cause of death worldwide.”

And we’re told that although there are very good treatments for strokes like this, they have to be administered within hours of the event… which means that people who don’t immediately get to a hospital are out of luck. This new treatment can be effective on people for much longer, which is why the market for the drug could be dramatically larger… more from the ad…

“It’s not a drug in the traditional sense. It’s a stem cell therapy….

“It can effectively treat patients up to 36 hours after they’ve suffered a stroke…

“…which would make 90–95% of stroke patients eligible for treatment.

“This is a HUGE milestone for modern medicine.”

OK, so there’s our confirmation of the “stem cell” idea. What else do we learn about this secret stock? More clues from the pitch…

“We’re looking at late-stage clinical trials that are already well underway.

“But this cell therapy has even more exciting applications.

“Aside from stroke, one of the main killers of people worldwide…

“… it can treat the leading cause of death from COVID-19:

Are you getting our free Daily Update
"reveal" emails? If not,
just click here...